Up a level |
Number of items: 2.
Dietlein, F., Kalb, B., Jokic, M., Torgovnick, A., Schmitt, A., Buettner, R., Thomas, R. and Reinhardt, H. C. (2015). Combined Chk1-and MK2-inhibition displays robust synergy in KRAS-mutant cancer. Oncol. Res. Treat., 38. S. 169 - 170. BASEL: KARGER. ISSN 2296-5262
Thelen, L., Chen, S., Riabinska, A., Daheim, M., Jokic, M., Thomas, R. and Reinhardt, C. (2014). Therapeutic targeting of a robust non-oncogene addiction to PRKDC in DNA repair-defective tumors. Oncol. Res. Treat., 37. S. 97 - 98. BASEL: KARGER. ISSN 2296-5262